|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT2013042813154N1 |
|
Date of registration:
|
2013-07-20 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Effect of Probiotic Yogurt in Prevention of Urinary Tract Infection
|
|
Scientific title:
|
Efficacy of the Probiotic Yogurt in Prevention of Urinary Tract Infection among People with Stroke, Hospitalized in the Hospital Affiliated with North Khorasan University of Medical Sciences in 2011-2012 |
|
Date of first enrolment:
|
2012-09-22 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/13077 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention.
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Batoul Mahmoudi
|
|
Address:
|
Imam khomeini Hospital, Imam Reza St, Shirvan, North Khorasan
Shirvan
Iran (Islamic Republic of) |
|
Telephone:
|
+98 58 5622 4011 |
|
Email:
|
bt438@nkums.ac.ir |
|
Affiliation:
|
North Khorasan University of medical Sciences |
|
|
Name:
|
Batoul Mahmoudi
|
|
Address:
|
Imam Khomeini Hospital, Imam Reza st, Shirvan, North Khorasan
Shirvan
Iran (Islamic Republic of) |
|
Telephone:
|
+98 58 5622 4011 |
|
Email:
|
bt438@nkums.ac.ir |
|
Affiliation:
|
North Khorasan University of Medical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion Criteria: negative urine cultivation; starting to eat and bear food; use of urinary catheter; undergoing no antibiotic treatment and willingness to participate in the research.
Exclusion criteria: immunosuppression; taking corticosteroids; inability to eat food and starting antibiotic treatment during the research.
Exclusion criteria:
Age minimum:
no limit
Age maximum:
no limit
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Urinary tract infection, site not specified
|
|
B95,B96,B9
|
Urinary tract infection.
Urinary tract infection, site not specified
|
|
Intervention(s)
|
|
Control group received 200 gr daily of normal yogurt 1/5% fat containing normal yogurt starter bacteria (Streptococcus thermophilus, Lactobacillus bulgaricus ) for a period 3 days.
|
|
Prevention
|
|
Intervention 1: The intervention group received 200 gr daily probiotic yogurt 1/5% fat containing yogurt starter bacteria plus Lactobacillus acidofillus LA-5 & Bifidobacterium BB-12 for a period of 3 days. Intervention 2: Control group received 200 gr daily of normal yogurt 1/5% fat containing normal yogurt starter bacteria (Streptococcus thermophilus, Lactobacillus bulgaricus ) for a period 3 days.
|
|
The intervention group received 200 gr daily probiotic yogurt 1/5% fat containing yogurt starter bacteria plus Lactobacillus acidofillus LA-5 & Bifidobacterium BB-12 for a period of 3 days.
|
|
Primary Outcome(s)
|
|
Prevention of urinary tract infection. Timepoint: The first day & fourth day. Method of measurement: Urine culture.
|
|
Source(s) of Monetary Support
|
|
Vice chancellor for research, North Khorasan University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Ethics Committee of the University of Medical Sciences
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|